Related Experiment Video
Updated: Jun 16, 2026

Tubal Cytology of the Fallopian Tube as a Promising Tool for Ovarian Cancer Early Detection
Published on: July 25, 2017
[Pre-pregnancy and early clinical analysis of TORCH infections detection]
1Family Planning Service Station of Yan Cheng County, Shandong Province 276100, China.
Insights
Early detection and treatment of TORCH infections in pregnant individuals are crucial for population health. This study highlights the necessity of timely diagnosis and intervention for TORCH infections to improve outcomes.
Area of Science:
- Medical Microbiology
- Immunology
- Maternal Health
Context:
- TORCH infections pose significant risks during pregnancy, potentially impacting fetal development and population quality.
- Early identification and management of TORCH infections are vital for effective public health strategies.
Purpose:
- To investigate the prevalence of TORCH infections in pregnant women.
- To evaluate the efficacy of Enzyme-linked immunosorbent assay (ELISA) for detecting TORCH pathogen-specific IgM antibodies.
- To emphasize the importance of early diagnosis, treatment, and prevention of TORCH infections.
Summary:
- A study involving 319 pregnant individuals utilized ELISA to detect TORCH pathogen-specific IgM antibodies in peripheral blood.
- The overall TORCH infection rate was 3.28%, with specific rates for Toxoplasmosis (TOX-IgM), Rubella (RV-IgM), Cytomegalovirus (CMV-IgM), and Herpes Simplex Virus type II (HSV-II-IgM) at 0.103%, 2.64%, 0.309%, and 0.237%, respectively.
- Of the 319 TORCH-infected cases, 97.49% received treatment, underscoring the need for prompt medical intervention.
Impact:
- Early diagnosis and treatment of TORCH infections can significantly improve maternal and infant health outcomes.
- Implementing routine screening and timely intervention strategies can contribute to enhancing population quality by preventing congenital TORCH infections.
- This research reinforces the critical role of serological testing in managing TORCH infections during pregnancy.
Objective:
For the birth, to improve the quality of the population, to explore the prevention and treatment of early pregnancy TORCH infection, and treatment of patients with positive eugenics and guidance.
Methods:
Enzyme-linked immunosorbent assay (ELISA) testing of all the objects in the peripheral blood-money pathogen-specific antibodies LgM. Person in charge of testing. In strict accordance with the instructions. Reagents from Shanghai magnolia biotechnology institute.
Result:
The total number of 319 cases of positive, with a total infection rate: 3.28%, TOX-IgM, RV-IgM, CMV-IgM, HSV (II)-IgM infection rate of 0.103 percent, 2.64 percent and 0.309 percent, 0.237 percent; 319 cases of TORCH infected persons are to receive treatment for the treatment of wrap, with a total negative rate of 97.49 percent.
Conclusion:
Detection of TORCH infections to ensure early diagnosis, early treatment and early prevention is necessary.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Rapid Identification of Pathogens
Acute Pyelonephritis II: Diagnostic Studies and Management